Metabolomics profiling of the free and total oxidised lipids in urine by LC-MS/MS: application in patients with rheumatoid arthritis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1618-2650
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Metabolomics profiling of the free and total oxidised lipids in urine by LC-MS/MS: application in patients with rheumatoid arthritis ; day:12 ; month:7 ; year:2016 ; pages:1-13
Analytical and bioanalytical chemistry ; (12.7.2016), 1-13
- Urheber
-
Fu, Junzeng
- Beteiligte Personen und Organisationen
-
Schoeman, Johannes C.
Harms, Amy C.
van Wietmarschen, Herman A.
Vreeken, Rob J.
BERGER, RUUD
Cuppen, Bart V. J.
Lafeber, Floris P. J. G.
van der Greef, Jan
Hankemeier, Thomas
SpringerLink (Online service)
- DOI
-
10.1007/s00216-016-9742-2
- URN
-
urn:nbn:de:1111-20160719262
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Fu, Junzeng
- Schoeman, Johannes C.
- Harms, Amy C.
- van Wietmarschen, Herman A.
- Vreeken, Rob J.
- BERGER, RUUD
- Cuppen, Bart V. J.
- Lafeber, Floris P. J. G.
- van der Greef, Jan
- Hankemeier, Thomas
- SpringerLink (Online service)
Ähnliche Objekte (12)
Drosophila ecdysteroidome by LC-MS/MS
Untargeted LC–MS/MS analysis reveals metabolomics feature of osteosarcoma stem cell response to methotrexate
Inferring serum proteolytic activity from LC-MS/MS data
Entwicklung von Screeningverfahren für Arzneistoffe und Metaboliten mittels LC-MS und LC-MS-MS
Entwicklung von Screeningverfahren für Arzneistoffe und Metaboliten mittels LC-MS und LC-MS-MS
Method development for the analysis of bioactive lipids by liquid chromatography tandem mass spectrometry (LC-MS-MS)
Optimal precursor ion selection for LC-MS/MS based proteomics
Visualization of LC‐MS/MS proteomics data in MaxQuant
Optimal precursor ion selection for LC-MS/MS based proteomics
Interrogating data-independent acquisition LC–MS/MS for affinity proteomics
LC-MS/MS based metabolomics and proteomics reveal candidate biomarkers and molecular mechanism of early IgA nephropathy
Steroid hormone analysis via LC-MS/MS in clinical routine diagnostics
Drosophila ecdysteroidome by LC-MS/MS
Untargeted LC–MS/MS analysis reveals metabolomics feature of osteosarcoma stem cell response to methotrexate
Inferring serum proteolytic activity from LC-MS/MS data
Entwicklung von Screeningverfahren für Arzneistoffe und Metaboliten mittels LC-MS und LC-MS-MS
Entwicklung von Screeningverfahren für Arzneistoffe und Metaboliten mittels LC-MS und LC-MS-MS
Method development for the analysis of bioactive lipids by liquid chromatography tandem mass spectrometry (LC-MS-MS)
Optimal precursor ion selection for LC-MS/MS based proteomics
Visualization of LC‐MS/MS proteomics data in MaxQuant
Optimal precursor ion selection for LC-MS/MS based proteomics
Interrogating data-independent acquisition LC–MS/MS for affinity proteomics
LC-MS/MS based metabolomics and proteomics reveal candidate biomarkers and molecular mechanism of early IgA nephropathy
Steroid hormone analysis via LC-MS/MS in clinical routine diagnostics
Drosophila ecdysteroidome by LC-MS/MS
Untargeted LC–MS/MS analysis reveals metabolomics feature of osteosarcoma stem cell response to methotrexate
Inferring serum proteolytic activity from LC-MS/MS data
Entwicklung von Screeningverfahren für Arzneistoffe und Metaboliten mittels LC-MS und LC-MS-MS
Entwicklung von Screeningverfahren für Arzneistoffe und Metaboliten mittels LC-MS und LC-MS-MS
Method development for the analysis of bioactive lipids by liquid chromatography tandem mass spectrometry (LC-MS-MS)
Optimal precursor ion selection for LC-MS/MS based proteomics
Visualization of LC‐MS/MS proteomics data in MaxQuant
Optimal precursor ion selection for LC-MS/MS based proteomics
Interrogating data-independent acquisition LC–MS/MS for affinity proteomics
LC-MS/MS based metabolomics and proteomics reveal candidate biomarkers and molecular mechanism of early IgA nephropathy